proactive investors article
*.com.au/companies/news/979621/radiopharm-theranostics-transformative-acquisition-and-progress-in-clinical-trials-to-drive-value-diamond-equity-research-979621.html?viewSource=TwitterAUe
- Forums
- ASX - By Stock
- RAD
- Ann: Change of Director's Interest Notice - IT
Ann: Change of Director's Interest Notice - IT, page-12
Featured News
Add RAD (ASX) to my watchlist
|
|||||
Last
3.3¢ |
Change
0.003(10.0%) |
Mkt cap ! $13.81M |
Open | High | Low | Value | Volume |
3.0¢ | 3.3¢ | 3.0¢ | $23.98K | 780.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 28570 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 0.033 |
1 | 88090 | 0.032 |
1 | 262475 | 0.030 |
6 | 745800 | 0.028 |
1 | 70000 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 28570 | 1 |
0.035 | 296498 | 3 |
0.036 | 503225 | 2 |
0.038 | 237463 | 2 |
0.045 | 78510 | 1 |
Last trade - 13.03pm 19/06/2024 (20 minute delay) ? |
Featured News
RAD (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online